INSIGHTS ON DRUG DEVELOPMENT

• Evolving Gene Editing For Rare Disease Drug Development

  Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.

• Use Of Reconstructed Tissue And 3D Printed CT-Based Nasal Casts

  Reconstructed nasal epithelium and CT-based 3D nasal casts provide more predictive, physiologically relevant models for assessing nasal drug delivery, improving accuracy in formulation development.

• Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability

  A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

• Process Intensification: Your Guide To "Doing More With Less"

  Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.

• Enhance Cell Line Development With Rapid Whole-Well Imaging

  11/7/2025

  Whole-well imaging streamlines clone selection by enabling rapid, automated analysis of single-cell growth and morphology, which reduces manual effort and improves reproducibility.

• In Vitro Drug Screening On Cancer Cells

  10/29/2025

  Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.

• ITC For Binding Characterization In Pharmaceutical Research

  4/24/2025

  Discover an Isothermal Titration Calorimetry tool that is precise for characterizing molecular interactions, which is crucial for drug discovery and lead optimization in pharmaceutical research.

• The Power Couple: CRISPR And Oligonucleotides

  3/4/2024

  Drug design using CRISPR depends on long guide RNA (gRNA) sequences. Find out how this match between long oligos and CRISPR works.

• Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight

  7/23/2024

  By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.